Back to Search
MONICA BROCCO, MD
MD
Emergency Medicine Physician
NPI: 1851610810Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Cellular and behavioural profile of the novel, selective neurokinin1 receptor antagonist, vestipitant: a comparison to other agents.
PMID 18657401·Eur Neuropsychopharmacol·2008
4-observational
Antidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
PMID 17021388·Behav Pharmacol·2006
7-preclinical
Neurotrophic factors and depolarization do not enhance viability and process regrowth on a purified set of chick embryo retinal ganglion cells.
PMID 12147311·Neurosci Lett·2002
7-preclinical
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
PMID 11888558·Pharmacol Biochem Behav·2002
7-preclinical
Neurokinin1 antagonists potentiate antidepressant properties of serotonin reuptake inhibitors, yet blunt their anxiogenic actions: a neurochemical, electrophysiological, and behavioral characterization.
PMID 18830239·Neuropsychopharmacology·2009
7-preclinical
Chronic restraint stress impairs T-cell immunity and promotes tumor progression in mice.
PMID 18609297·Stress·2009
7-preclinical
S32006, a novel 5-HT2C receptor antagonist displaying broad-based antidepressant and anxiolytic properties in rodent models.
PMID 18523738·Psychopharmacology (Berl)·2008
7-preclinical
The melanin-concentrating hormone1 receptor antagonists, SNAP-7941 and GW3430, enhance social recognition and dialysate levels of acetylcholine in the frontal cortex of rats.
PMID 18466669·Int J Neuropsychopharmacol·2008
7-preclinical
Inhibitory effect of fluoxetine on lymphoma growth through the modulation of antitumor T-cell response by serotonin-dependent and independent mechanisms.
PMID 18342838·Biochem Pharmacol·2008
7-preclinical
S33138 (N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1] benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenyl-acetamide), a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: III. Actions in models of therapeutic activity and induction of side effects.
PMID 18096759·J Pharmacol Exp Ther·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 3400 SPRUCE ST, GROUND SILVERSTEIN BLDG
PHILADELPHIA, PA 19104 - Phone
- (215) 662-6698
Quick Facts
- NPI
- 1851610810
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile